PubMed=11175312; DOI=10.1038/sj.gt.3301349
Schendel D.J., Frankenberger B., Jantzer P., Cayeux S., Noessner E., Willimsky G., Maget B., Pohla H., Blankenstein T.
Expression of B7.1 (CD80) in a renal cell carcinoma line allows expansion of tumor-associated cytotoxic T lymphocytes in the presence of an alloresponse.
Gene Ther. 7:2007-2014(2000)

PubMed=15755994; DOI=10.1158/1078-0432.CCR-04-1883
Frankenberger B., Pohla H., Noessner E., Willimsky G., Papier B., Pezzutto A., Kopp J., Oberneder R., Blankenstein T., Schendel D.J.
Influence of CD80, interleukin-2, and interleukin-7 expression in human renal cell carcinoma on the expansion, function, and survival of tumor-specific CTLs.
Clin. Cancer Res. 11:1733-1742(2005)

PubMed=16045799; DOI=10.1186/1479-5876-3-29; PMCID=PMC1188079
Geiger C., Regn S., Weinzierl A., Noessner E., Schendel D.J.
A generic RNA-pulsed dendritic cell vaccine strategy for renal cell carcinoma.
J. Transl. Med. 3:29.1-29.15(2005)